- Article
Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Analysis
- Aya Takahashi,
- Michihisa Moriguchi,
- Yuya Seko,
- Toshihide Shima,
- Yasuhide Mitsumoto,
- Hidetaka Takashima,
- Hiroyuki Kimura,
- Hideki Fujii,
- Hiroki Ishikawa and
- Takaharu Yo
- + 16 authors
We investigated the association between early tumor shrinkage (ETS) and treatment outcome in patients with hepatocellular carcinoma treated with lenvatinib (LEN). A retrospective analysis was performed in 104 patients. ETS was defined as tumor shrink...

